These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22743149)

  • 41. Efficacy and safety of nonsteroidal anti-inflammatory drugs in Asian patients with knee osteoarthritis: summary of a randomized, placebo-controlled study.
    Essex MN; O'Connell MA; Behar R; Bao W
    Int J Rheum Dis; 2016 Mar; 19(3):262-70. PubMed ID: 25990559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety and efficacy of topical diclofenac sodium gel for knee osteoarthritis in elderly and younger patients: pooled data from three randomized, double-blind, parallel-group, placebo-controlled, multicentre trials.
    Baraf HS; Gloth FM; Barthel HR; Gold MS; Altman RD
    Drugs Aging; 2011 Jan; 28(1):27-40. PubMed ID: 21174485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Duloxetine Reduces Pain and Improves Quality of Recovery Following Total Knee Arthroplasty in Centrally Sensitized Patients: A Prospective, Randomized Controlled Study.
    Koh IJ; Kim MS; Sohn S; Song KY; Choi NY; In Y
    J Bone Joint Surg Am; 2019 Jan; 101(1):64-73. PubMed ID: 30601417
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A double-blind randomized placebo controlled study assessing safety, tolerability and efficacy of palmitoylethanolamide for symptoms of knee osteoarthritis.
    Steels E; Venkatesh R; Steels E; Vitetta G; Vitetta L
    Inflammopharmacology; 2019 Jun; 27(3):475-485. PubMed ID: 30927159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of mobilization with movement on pain and function in patients with knee osteoarthritis: a randomized double-blind controlled trial.
    Alkhawajah HA; Alshami AM
    BMC Musculoskelet Disord; 2019 Oct; 20(1):452. PubMed ID: 31627723
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.
    Smith EM; Pang H; Cirrincione C; Fleishman S; Paskett ED; Ahles T; Bressler LR; Fadul CE; Knox C; Le-Lindqwister N; Gilman PB; Shapiro CL;
    JAMA; 2013 Apr; 309(13):1359-67. PubMed ID: 23549581
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.
    Welsch P; Üçeyler N; Klose P; Walitt B; Häuser W
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD010292. PubMed ID: 29489029
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome.
    Häuser W; Urrútia G; Tort S; Uçeyler N; Walitt B
    Cochrane Database Syst Rev; 2013 Jan; (1):CD010292. PubMed ID: 23440848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fish oil in knee osteoarthritis: a randomised clinical trial of low dose versus high dose.
    Hill CL; March LM; Aitken D; Lester SE; Battersby R; Hynes K; Fedorova T; Proudman SM; James M; Cleland LG; Jones G
    Ann Rheum Dis; 2016 Jan; 75(1):23-9. PubMed ID: 26353789
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Duloxetine versus placebo in the treatment of stress urinary incontinence.
    Norton PA; Zinner NR; Yalcin I; Bump RC;
    Am J Obstet Gynecol; 2002 Jul; 187(1):40-8. PubMed ID: 12114886
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Duloxetine for the treatment of major depressive disorder: a closer look at efficacy and safety data across the approved dose range.
    Mallinckrodt CH; Prakash A; Andorn AC; Watkin JG; Wohlreich MM
    J Psychiatr Res; 2006 Jun; 40(4):337-48. PubMed ID: 16271726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and performance of Hydros and Hydros-TA for knee osteoarthritis: a prospective, multicenter, randomized, double-blind feasibility trial.
    Petrella RJ; Emans PJ; Alleyne J; Dellaert F; Gill DP; Maroney M
    BMC Musculoskelet Disord; 2015 Mar; 16():57. PubMed ID: 25887932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of preoperative duloxetine treatment on postoperative chronic residual pain after total hip or knee arthroplasty: a randomised controlled trial.
    Rienstra W; Blikman T; Dijkstra B; Stewart R; Zijlstra W; van Raaij T; Ten Hagen A; Bulstra S; Stevens M; van den Akker-Scheek I
    BMJ Open; 2021 Nov; 11(11):e052944. PubMed ID: 34732491
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Perahia DG; Wang F; Mallinckrodt CH; Walker DJ; Detke MJ
    Eur Psychiatry; 2006 Sep; 21(6):367-78. PubMed ID: 16697153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rescue pharmacotherapy with duloxetine for selective serotonin reuptake inhibitor nonresponders in late-life depression: outcome and tolerability.
    Karp JF; Whyte EM; Lenze EJ; Dew MA; Begley A; Miller MD; Reynolds CF
    J Clin Psychiatry; 2008 Mar; 69(3):457-63. PubMed ID: 18251622
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Duloxetine for the treatment of major depressive disorder in older patients.
    Nelson JC; Wohlreich MM; Mallinckrodt CH; Detke MJ; Watkin JG; Kennedy JS
    Am J Geriatr Psychiatry; 2005 Mar; 13(3):227-35. PubMed ID: 15728754
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial.
    Millard RJ; Moore K; Rencken R; Yalcin I; Bump RC;
    BJU Int; 2004 Feb; 93(3):311-8. PubMed ID: 14764128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and Safety of Honey Bee Venom (
    Conrad VJ; Hazan LL; Latorre AJ; Jakubowska A; Kim CMH
    J Altern Complement Med; 2019 Aug; 25(8):845-855. PubMed ID: 31274334
    [No Abstract]   [Full Text] [Related]  

  • 59. Paracetamol versus placebo for knee and hip osteoarthritis.
    Leopoldino AO; Machado GC; Ferreira PH; Pinheiro MB; Day R; McLachlan AJ; Hunter DJ; Ferreira ML
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013273. PubMed ID: 30801133
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fasinumab (REGN475), an antibody against nerve growth factor for the treatment of pain: results from a double-blind, placebo-controlled exploratory study in osteoarthritis of the knee.
    Tiseo PJ; Kivitz AJ; Ervin JE; Ren H; Mellis SJ
    Pain; 2014 Jul; 155(7):1245-1252. PubMed ID: 24686255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.